Therefore, Tyr/Phe ratio could be considered as a measure for phenylalanine hydroxylase enzyme activity in CKD patients which making this ratio as a potential biomarker for the detection of the disease in its early stages. The gene discussed is PAH; the disease is chronic kidney disease.